EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

N‐methyl‐D ‐aspartic acid receptor 2A functionalized stationary phase: A reliable method for pursuing potential ligands against Alzheimer's disease from natural products

Yuan-Yuan Chen, Yan Xue, Jia-Tai Yin, Le-Jing Qu, Hao-Peng Li, Qian Li, Xin-Feng Zhao iD

CNS Neuroscience & Therapeutics · 2023

DOI: 10.1111/cns.14101 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2023. Verfasst von Yuan-Yuan Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Northwest University, Xi'an, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Biological Products. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shaanxi Administration of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

N‐methyl‐D‐aspartic acid (NMDA) receptors play subunit‐specific role in central neuronal development. However, insights into the pharmacological modulation of NMDA receptors were mainly lack of subunit and synaptic selectivity. The purpose of the present study was to develop a novel strategy to rapidly recognize NMDA subunit 2A (NMDA‐2A) ligands from natural products and provide subunit‐selective drug candidates for Alzheimer's disease (AD).

Methods

The recombinant NMDA‐2A containing a tag of epidermal growth factor receptor (EGFR) was expressed in Escherichia coli cells and immobilized on ibrutinib‐modified microspheres based on the specific reaction between EGFR and its inhibitor ibrutinib. A novel affinity stationary phase was synthesized to screen NMDA‐2A ligands from Gardenia jasminoides Ellis.

Results

The immobilized receptor column exhibited excellent receptor selectivity and ligand‐binding activity. Crocetin was screened by using this method. In a cellular model of AD, the protein level of NMDA‐2A was significantly decreased compared with the control group, while treatment with crocetin significantly increased NMDA‐2A level in a concentration‐dependent manner, confirming that crocetin could bind to NMDA‐2A in vitro.

Conclusion

In the present study, we developed a reliable method for the rapid identification of NMDA‐2A ligands from natural products, which may be used as a platform for new drug discovery to generate high‐quality drug candidates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseBiological ProductsHumansReceptors, N-Methyl-D-AspartateN-MethylaspartateLigandsCarotenoidsVitamin A

Stichwörter der Autor:innen

Alzheimer's diseaseNMDA receptoraffinity chromatographydrug discoverynatural products

Substanzen

Receptors, N-Methyl-D-AspartateN-MethylaspartateLigandsBiological Productstrans-sodium crocetinateCarotenoidsVitamin A

Autor:innen und Institutionen

  • College of Life Sciences, Northwest University, Xi'an, China.

ORCID-Profile: Xin-Feng Zhao

Förderung

  • National Natural Science Foundation of China
  • Shaanxi Administration of Traditional Chinese Medicine

Zitieren

APA

Chen, Y. Y., Xue, Y., Yin, J. T., Qu, L. J., Li, H. P., Li, Q., & Zhao, X. F. (2023). N‐methyl‐D ‐aspartic acid receptor 2A functionalized stationary phase: A reliable method for pursuing potential ligands against Alzheimer's disease from natural products. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.14101

Vancouver

Chen YY, Xue Y, Yin JT, Qu LJ, Li HP, Li Q, et al. N‐methyl‐D ‐aspartic acid receptor 2A functionalized stationary phase: A reliable method for pursuing potential ligands against Alzheimer's disease from natural products. CNS Neuroscience & Therapeutics. 2023. doi:10.1111/cns.14101

BibTeX
@article{Chen2023,
  author = {Chen, Yuan-Yuan and Xue, Yan and Yin, Jia-Tai and Qu, Le-Jing and Li, Hao-Peng and Li, Qian and Zhao, Xin-Feng},
  title = {N‐methyl‐D ‐aspartic acid receptor 2A functionalized stationary phase: A reliable method for pursuing potential ligands against Alzheimer's disease from natural products},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2023},
  doi = {10.1111/cns.14101}
}
Kostenlos starten →